A call to action: A need for initiatives that increase equitable access to COVID-19 therapeutics.

Abdul-Mutakabbir, Jacinda C; Hirsch, Elizabeth B; Ko, Caroline; Brown, Britny R; Bandali, Aiman; Mordino, Jason; Yoke, Leah H; Bell, Taison; Swartz, Talia H; Syed, Uzma; Hlatshwayo, Matifadza; Saunders, Ila M.

Afiliação

Abdul-Mutakabbir JC; Department of Pharmacy Practice, Loma Linda University School of Pharmacy, 24745 Stewart Street, Loma Linda CA 92350, USA.
Hirsch EB; Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Ko C; Department of Experimental & Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN, USA.
Brown BR; Santa Clara Valley Medical Center, San Jose, CA, USA.
Bandali A; University of Rhode Island College of Pharmacy, Kingston, RI, USA.
Mordino J; Atlantic Health System, Morristown, NJ, USA.
Yoke LH; Boston Medical Center, Boston, MA, USA.
Bell T; Fred Hutch Cancer Research Center, Seattle, WA, USA.
Swartz TH; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
Syed U; Division of Pulmonary/Critical Care Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
Hlatshwayo M; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai New York, NY, USA.
Saunders IM; South Shore Infectious Diseases and Travel Medicine Consultants Bay shore, New York, NY, USA.

Lancet Reg Health Am ; 11: 100263, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35600636

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article